Literature DB >> 11834068

Successful late reintervention after the arterial switch procedure.

Sanjiv K Gandhi1, Frank A Pigula, Ralph D Siewers.   

Abstract

BACKGROUND: The arterial switch operation is the therapy of choice for transposition of the great arteries.
METHODS: A retrospective analysis of all children undergoing the arterial switch operation between November 1985 and October 2000 was conducted, highlighting the frequency and nature of late invasive reintervention.
RESULTS: One hundred forty-four children were operated on. Operative survival was 89% (128 of 144). Late reintervention was required in 23% (29 of 128) of survivors. Neopulmonary stenosis (PS) was the most common complication requiring treatment, occurring in 16% (21 of 128) of patients. Eleven of 21 patients with PS required reoperation, whereas 10 were managed with percutaneous techniques. Other indications for reintervention included aortic arch obstruction (3 patients), ventricular septal defect (with PS in 2 patients), bronchial stenosis (2 patients), coronary stenosis (2 patients), aortic stenosis (with PS in 1 patient), and residual atrial septal defect (1 patient). There has been no mortality or major morbidity in those children who have undergone reintervention.
CONCLUSIONS: Invasive reintervention after the arterial switch operation is occasionally required. The most common indication is PS. Reintervention is well tolerated by those children who require it. Continued follow-up for late complications is required in this patient population.

Entities:  

Mesh:

Year:  2002        PMID: 11834068     DOI: 10.1016/s0003-4975(01)03292-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  1 in total

1.  Stenosis of the branches of the neopulmonary artery after the arterial switch operation: A cardiac magnetic resonance imaging study.

Authors:  Boban Thomas; José Diogo Ferreira Martins; Nuno Jalles Tavares; Artur Lopes; Fátima F Pinto; José Fragata
Journal:  Ann Pediatr Cardiol       Date:  2013-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.